Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma
- PMID: 11691817
Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma
Abstract
Sixty-six replacing growth-type early lung adenocarcinomas, measuring 2 cm or less across their greatest dimension, were used to investigate allelic losses at eight loci on the eight chromosomes carrying the principal cancer-associated genes. In total, 2 (16.7%) of 12 type A tumors (localized bronchioloalveolar carcinoma, LBAC) and 11 (39.3%) of 28 type B tumors (LBAC with alveolar collapse), which correspond to early lung adenocarcinomas including cancers in situ, showed allelic losses in one or more of the regions examined. In contrast, 25 (96.2%) of 26 type C tumors (LBAC with active fibroblastic proliferation), which correspond to small but advanced tumors, showed allelic losses in one or more regions. The change in histology from type A to type C was characterized by a significant rise in the incidence of allelic losses (P < 0.01). Deletions of 3p, 17p, 18q, and 22q increased significantly during malignant progression. In type C tumors that showed heterogeneous histological features, the tumor cells in the central fibrotic areas exhibited more allelic losses than those in the peripheral bronchioloalveolar growths and were, therefore, considered to have progressed to a more advanced stage than the tumor cells in the peripheral regions.
Similar articles
-
Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.Br J Cancer. 2004 Sep 13;91(6):1143-8. doi: 10.1038/sj.bjc.6602005. Br J Cancer. 2004. PMID: 15292942 Free PMC article.
-
Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.Cancer Res. 1994 Nov 1;54(21):5643-8. Cancer Res. 1994. PMID: 7923210
-
Analysis of loss of heterozygosity in small adenocarcinomas of the lung.Jpn J Clin Oncol. 1998 Apr;28(4):240-4. doi: 10.1093/jjco/28.4.240. Jpn J Clin Oncol. 1998. PMID: 9657008
-
SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.Ann Thorac Surg. 2004 Nov;78(5):1734-41. doi: 10.1016/j.athoracsur.2004.05.056. Ann Thorac Surg. 2004. PMID: 15511464 Review.
-
Small peripheral pulmonary adenocarcinoma: morphologic and molecular update.Adv Anat Pathol. 2007 Mar;14(2):120-8. doi: 10.1097/PAP.0b013e3180324519. Adv Anat Pathol. 2007. PMID: 17471118 Review.
Cited by
-
Expression of Transforming Growth Factor β1 and E-Cadherin Proteins in Pulmonary Adenocarcinoma: Its Significance in Tumor Progression.Cancer Res Treat. 2013 Jun;45(2):118-25. doi: 10.4143/crt.2013.45.2.118. Epub 2013 Jun 30. Cancer Res Treat. 2013. PMID: 23864845 Free PMC article.
-
Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.Br J Cancer. 2004 Sep 13;91(6):1143-8. doi: 10.1038/sj.bjc.6602005. Br J Cancer. 2004. PMID: 15292942 Free PMC article.
-
Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis.Onco Targets Ther. 2020 Apr 14;13:3085-3091. doi: 10.2147/OTT.S248436. eCollection 2020. Onco Targets Ther. 2020. PMID: 32341654 Free PMC article. Review.
-
Fibroblast phenotypes in different lung diseases.J Cardiothorac Surg. 2014 Sep 5;9:147. doi: 10.1186/s13019-014-0147-z. J Cardiothorac Surg. 2014. PMID: 25189096 Free PMC article.
-
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.Nat Commun. 2021 May 11;12(1):2722. doi: 10.1038/s41467-021-22890-x. Nat Commun. 2021. PMID: 33976164 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical